Projects

Tackling diabetic retinopathy in a megalopolis – the case of Mexico city, WDF15-1223

WDF15-1223
The project is dedicated to eliminating needless blindness in Mexico and creating an effective diabetic retinopathy primary care detection programme, and has the potential for replication in other large cities across the world.
Diabetic retinopathy, Mexico City
WDF 15-1223 is introducing diabetic retinopathy screening and care in marginalised urban areas.

Mexico is one of the 10 countries with most diabetes in the world, with a prevalence of 11.92%. Diabetes was responsible for 13.7% of Mexican deaths in 2011 and diabetes is therefore the number 1 cause of national mortality.

According to a 2012 survey, the most common complication of diabetes is diabetic retinopathy with almost four million people suffering from poor vision or retinal damage.

In addition to its costs for the individual, diabetes also deeply impacts Mexico’s economy, representing 17% of the total health budget. Diabetic retinopathy alone costs the Mexican government more than 100 million dollars annually in treatment costs.

 

Objectives

The goal of the project is to introduce diabetic retinopathy screening and care in marginalised urban areas.

 

Approach

The project targets private and public/private health facilities in low-income areas of Mexico City and Estado de Mexico, which have  a total population of more than 20 million. Access to diabetic retinopathy screening and diabetes care is low or non-existing in the areas targeted.

To acquire knowledge about diabetic retinopathy and diabetes across the communities targeted, a KAP study based on 300 interviews with HCPs and patients will be implemented.

Following the lessons learned, training of HCPs at primary level in diabetic retinopathy and diabetes will be applied through combined e-learning and training sessions.

In collaboration with targeted primary level health centres, 300 diabetic retinopathy/diabetes screening and awareness campaigns will be rolled out, with a mobile eye care unit deployed for that purpose. A telemedicine-based referral system for advanced eye care including laser treatment will be established.

To raise awareness about diabetes and eye complications, various educational activities and media/social media initiatives will be implemented, including collaboration with targeted primary level health centres and communities.

Finally, the pilot project model will be assessed through comprehensive monitoring and data collection, including a cost-effectiveness analysis.

 

Expected results

  • 5,000 HCPs trained, incl. through e-learning platform
  • 300 primary level health centres covering 300 urban/sub-urban communities reached through mobile unit based screening campaigns
  • 24,000 diabetic retinopathy screenings (retinal camera based) conducted
  • Estimated 6,000 cases referred for advanced eye care (laser)
  • Data to be collected on a range of clinical impact indicators
     

Project information

Project nr.: 
WDF15-1223
Project Status: 
Ongoing
Primary focus area: 
Region: 
North America and Caribbean
Address of head office: 
Mexico
Partners: 
SalaUNO
Project responsible: 
Javier Okhuysen
Project start date: 
2016 to 2018
Project budget: 
USD 388,148
WDF contribution: 
USD 197,840

Expected results

  • 5,000 HCPs trained, incl. through e-learning platform
  • 300 primary level health centres covering 300 urban/sub-urban communities reached through mobile unit based screening campaigns
  • 24,000 diabetic retinopathy screenings (retinal camera based) conducted
  • Estimated 6,000 cases referred for advanced eye care (laser)